Interstitial Lung Diseases Interdisciplinary Network
a hub for research, education & best practice
Advancing Interstitial
Lung Disease Healthcare:
A network serving as a valuable resource for healthcare professionals working in the field of ILD, promoting research, education, and best practice in the diagnosis and management of these lung disorders.
Support
The ILD-IN provides a supportive network for all members, encourages information sharing and promotes best practice and research collaboration.
Education
The ILD-IN provides resources and materials and encourages members to develop knowledge and expertise in ILD care.
Influence
Through peer support and education, the ILD-IN aims to raise the standard and provision of ILD care.
Join ILD-IN Today
Our purpose is to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
- Member Support
- Member Education
- Learning Resources
- Discounted Conferences Rates
Join ILD-IN today and become a vital part of the ILD healthcare revolution!
Annual Membership:
£25 per year
Find The Resources You're Looking For
members only
members only
About Us
The Interstitial Lung Disease Interdisciplinary Network (ILD-IN) is a supportive and collaborative network for health professionals of all disciplines caring for people with interstitial lung disease (ILD).
Latest News
Stay connected, stay informed. Explore our news articles and be at the forefront of ILD healthcare. Together, we strive for a brighter and healthier future for all those affected by ILD.
News
21st December 2021
Regional Networks
The ILD-IN is keen to support the development of regional networks supporting healthcare professionals specialising in ILD locally.
New and established regional groups and their contacts are listed along with details of the next planned meeting. We would be pleased to list your network.
What's Been Happening
Take a look at our social wall to stay up-to-date on the latest events and news in the industry.
;
Our paper is out in @accpchest comparing antifibrotics in IPF👇
https://journal.chestnet.org/article/S0012-3692(23)05827-0/fulltext
Great mix of talks at #BTS today discussing London underground pollution, chemicals from car tyres, silicosis, asbestosis and that we're still under reporting occupational cases. #alwaysaskaboutwork #SWORD #occupation @wigruth @lungsatwork @gwocclung @kimintheredcoat
Join the poster discussion session at 3:15pm to hear more about #ILD patient engagement with home monitoring
Join the poster discussion session at 3:15pm to hear more about #nintedanib in combination with immunosuppressants @GSTTnhs
Day 3 @BTSrespiratory is all about posters. So interesting to hear about the fantastic work going on in the world of #ILD
Day 3 @BTSrespiratory - lots of interesting discussions in the poster area with @RespPharmacist and @JoanneDallas20 - find the team and say hello!
Did you spot @RespPharmacist and @Istamina today? The @ild_inn committee members are in London for @BTSrespiratory and #OneVoiceILD
Day 2 @BTSrespiratory was all about meeting colleagues, friends and drivers of change. Really enjoyed sharing key findings and recommendations from @ild_inn service & workforce evaluation at #OneVoiceILD
Deprivation shown to be an independent predictive factor of mortality in IPF, with the most deprived having a 39% higher risk of death compared to the least deprived - Charaka Hadinnapola from @uniofeastanglia with data from @BTSrespiratory ILD Registry #BTSWinter2023